Maria Teresa Pallotta is a professor of pharmacology at the Department of Medicine and Surgery, University of Perugia, Italy. She graduated with honors in Drug Chemistry and Technology (2005) and obtained in 2011 the PhD degree in Biology and Experimental Medicine at the University of Perugia. The research carried out during her PhD contributed to identifying that besides its catalytic activity, IDO1 functions as a signaling molecule responsible for inducing long-term tolerance in dendritic cells. The Italian Society of Pharmacology and Farmaindustria awarded her for this publication. She spent the beginning of her post-doctoral experience (2011) at the Institute for Research in Biomedicine (IRB), Bellinzona (Swiss), where she acquired great expertise in confocal microscopy and FRET.  Since then, she has participated in several national and international grants, including one funded by the European Research Council (DIDO-ERC Advanced Grant ‘Innovative drugs targeting IDO molecular dynamics in autoimmunity and neoplasia’) in which she was involved as the main researcher. Since 2011, she has been a member of the "Italian Society of Pharmacology" (SIF). Her main research interests include immunopharmacology, immunotherapy, and tryptophan metabolism in regulating the immune response in autoimmune, neoplastic, and inflammatory chronic diseases.